80 results
8-K
EX-10.1
ANVS
Annovis Bio Inc
1 May 24
Departure of Directors or Certain Officers
5:18pm
statutory, regulatory, common law or other Claims of any kind, including, but not limited to, Claims for breach of contract, libel, slander, fraud
8-K
EX-10.1
ANVS
Annovis Bio Inc
26 Apr 24
Entry into a Material Definitive Agreement
8:14am
financial data; and (ii) any fraud, whether or not material, that involves management or other employees who have a role in the Company’s internal … by such Investor Party through its fraud, bad faith, gross negligence, or willful or reckless misconduct. Provided further, the Company shall
424B5
98m64g7s 9b
18 Mar 24
Prospectus supplement for primary offering
10:00pm
424B5
crnii0wzs
18 Mar 24
Prospectus supplement for primary offering
8:51pm
8-K
EX-1.1
jn8tf
1 Nov 23
Annovis Bio Announces Launch of Proposed Public Offering
12:28pm
424B5
gihc8p64iy8582qjf3
1 Nov 23
Prospectus supplement for primary offering
12:24pm
424B5
wr8wdcn7lkvyi6dk
30 Oct 23
Prospectus supplement for primary offering
5:27pm
D
dwgo viwbnqgymxx
24 Apr 23
$1.06 mm in equity, sold $1.06 mm, 6 investors
5:41pm
8-K
EX-1.1
ez8s5 w9l
3 Apr 23
Entry into a Material Definitive Agreement
5:28pm